Patents by Inventor Cheng Wang

Cheng Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12776258
    Abstract: A display panel and a display device are provided. The display panel includes a display area and a hole-digging area surrounded by the display area. The display panel includes a plurality of first scanning signal lines. The plurality of first scanning signal lines include a plurality of first type scanning signal lines. Each of the first type scanning signal lines includes a first part, a second part, and a third part. The first part and the second part are respectively located on opposite two sides of the hole-digging area and extend along a first direction. The third part is connected between the first part and the second part. An extension line of the first part passes through the hole-digging area. A unit length impedance of the third part is greater than a unit length impedance of the first part and a unit length impedance of the second part.
    Type: Grant
    Filed: April 30, 2025
    Date of Patent: October 27, 2026
    Assignee: WUHAN CHINA STAR OPTOELECTRONICS SEMICONDUCTOR DISPLAY TECHNOLOGY CO., LTD.
    Inventors: Huanxi Zhang, Cheng Wang
  • Patent number: 12776701
    Abstract: A harmonic suppression method and apparatus for a three-phase three-wire cascaded power conversion apparatus is disclosed.
    Type: Grant
    Filed: August 6, 2024
    Date of Patent: October 27, 2026
    Assignee: EATON INTELLIGENT POWER LIMITED
    Inventors: Jianxiong Yu, Jiajie Duan, Cheng Luo, Cheng Wang
  • Publication number: 20260327342
    Abstract: Provided herein are anti-human ? light chain antibodies or human ? light chain binding antibody fragments that bind an epitope specific of a misfolded human ? light chain. Also provided are polynucleotides encoding the same, and compositions comprising anti-human ? light chain antibodies or human ? light chain binding antibody fragments. The anti-human ? light chain antibodies or human ? light chain binding antibody fragments are useful for measuring human ? light chain in a biological sample comprising contacting the sample with the anti-human ? light chain antibodies or human ? light chain binding antibody fragments. The anti-human ? light chain antibodies or human ? light chain binding antibody fragments are also useful for reducing ? light chain aggregates. Additionally, the anti-human ? light chain antibodies or human ? light chain binding antibody fragments are useful for treating disorders or conditions associated with ? light chain aggregates.
    Type: Application
    Filed: April 9, 2026
    Publication date: October 22, 2026
    Inventors: Yulong SUN, Natalie GALANT, Julian DAVIES, Victoria ORTEGA, Cheng WANG
  • Publication number: 20260328620
    Abstract: A peak position measurement offset is determined in a two-dimensional optical spectrum. A plurality of peaks are identified that appear in both: a spectrum obtained from a reference material at known conditions; and a spectrum obtained from a sample of interest. The peak position measurement offset is determined by a comparison of a pattern formed by peak positions of the plurality of identified peaks in the spectrum obtained from the sample of interest against the plurality of identified peaks in the spectrum obtained from the reference material.
    Type: Application
    Filed: July 2, 2026
    Publication date: October 22, 2026
    Applicants: Thermo Fisher Scientific (Bremen) GmbH, Thermo Fisher Scientific (Shanghai) Instruments Co., Ltd.
    Inventors: Shenghai Wu, Antonella Guzzonato, Cheng Wang
  • Publication number: 20260327185
    Abstract: The present invention relates to an ionizable lipid compound, a lipid carrier comprising same and the use thereof. Provided in the present invention are a series of compounds as represented by formula (1), a lipid carrier comprising same as an ionizable lipid, a nucleic acid lipid nanoparticle composition and a preparation thereof. A lipid nanoparticle formed from the ionizable lipid can deliver a nucleic acid molecule into the body, so that the transfer rate of a nucleic acid molecule is increased, and the treatment effect of a nucleic acid drug is improved.
    Type: Application
    Filed: June 4, 2024
    Publication date: October 22, 2026
    Inventors: Xinghua PAN, Cheng WANG
  • Publication number: 20260323476
    Abstract: A user equipment (UE) performs a method that comprises preparing an announcement message for transmission, the announcement message comprising an indication of a capability of the user equipment to act as a relay in a UE-to-UE (U2U) connection and, responsive to a determination that the UE is connected to a radio communication network, an indication that network-based security protocols are available to establish security for the U2U connection.
    Type: Application
    Filed: July 27, 2023
    Publication date: October 15, 2026
    Inventor: Cheng Wang
  • Patent number: 12759964
    Abstract: A method for preparing a phenoxycarboxylate includes 1) allowing a salt of a phenolic compound and a halogenated carboxylate to subject to a condensation reaction in a polar solvent under the action of a catalyst; and 2) adding an acid-containing organic solvent to the condensation reaction liquid in step 1) to perform an acidification, and purifying the precipitated halogenated inorganic salt to obtain a phenoxycarboxylate. A catalyst is added in the condensation process, which can improve the reaction rate, achieve the reaction at room temperature and high material conversion rate, and avoid the problem in the prior art that the reaction needs to be performed at high temperature, about 120° C. After the condensation reaction is completed, the salt is removed by dry filtration (an anhydrous condition) by adding a methanol hydrogen chloride solution. There is no industrial wastewater, raw materials are easily recycled, and the reaction yield is high.
    Type: Grant
    Filed: December 30, 2023
    Date of Patent: October 13, 2026
    Assignee: SHANDONG WEIFANG RAINBOW CHEMICAL CO., LTD
    Inventors: Zhiqing Li, Xiaopeng Huang, Cheng Wang, Fujun Han, Changtao Zhou, Qiang Liu, Qifan Wu, Guangli Zhao
  • Patent number: 12756629
    Abstract: Embodiments include methods for a first network function, NF, configured to operate as a server of a federated learning, FL, group in a communication network. Such methods include registering the following information in a network repository function, NRF, of the communication network: a vendor ID associated with the first NF, and an interoperability ID that corresponds to one or more vendor IDs associated with further NFs authorized to join the FL group as clients. Such methods include receiving an indication of a second NF, of the communication network, that is a candidate client for the FL group, and creating or updating the FL group including the second NF as a client, based on one of the following: a first token indicating that the first NF is authorized to add the second NF to the FL group as a client; or a second token indicating that the second NF is authorized to join the FL group as a client.
    Type: Grant
    Filed: November 7, 2023
    Date of Patent: October 6, 2026
    Assignee: Telefonaktiebolaget LM Ericsson (publ)
    Inventors: Cheng Wang, Ferhat Karakoc, Dan Xu, Jing Yue
  • Patent number: 12753230
    Abstract: Provided are an anti-Nectin-4 antibody or antigen-binding fragment thereof, an antibody conjugate comprising the same, and use thereof in the manufacture of a medicament, particularly in the manufacture of a medicament for treating and/or preventing cancer.
    Type: Grant
    Filed: September 6, 2021
    Date of Patent: October 6, 2026
    Assignee: SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.
    Inventors: Cheng Wang, Dengnian Liu, Fen Li, Liang Xiao, Tongtong Xue, Junyou Ge, Jingyi Wang, Le Liu, Qi Ren
  • Patent number: 12755577
    Abstract: A multi-view human action recognition method based on hypergraph learning, comprising acquiring video data from P views, and further comprising the following steps: pre-processing the video data; constructing spatial hypergraphs based on joint information; constructing temporal hypergraphs based on the joint information; performing feature learning of the spatial hypergraphs and the temporal hypergraphs using hypergraph neural networks; and extracting higher order information represented by the hypergraphs, and performing action recognition of human actions.
    Type: Grant
    Filed: November 13, 2023
    Date of Patent: October 6, 2026
    Assignee: Beijing University Of Technology
    Inventors: Nan Ma, Ye Liang, Cong Guo, Cheng Wang, Genbao Xu
  • Publication number: 20260294810
    Abstract: The present invention relates to an ionizable lipid compound, a lipid carrier comprising same, and an application of the ionizable lipid compound. The present invention provides a series of compounds as shown in formula (1), a lipid carrier comprising same as an ionizable lipid, a nucleic acid lipid nanoparticle composition, and a preparation thereof. Lipid nanoparticles formed by the ionizable lipid can deliver nucleic acid molecules into cells, thus increasing the transfer rate of the nucleic acid molecules, and thereby improving the treatment effect of a nucleic acid drug.
    Type: Application
    Filed: April 9, 2024
    Publication date: October 1, 2026
    Inventors: Xinghua PAN, Cheng WANG
  • Publication number: 20260297613
    Abstract: Methods and compositions are provided for integrating coding sequences for antigen-binding proteins such as broadly neutralizing antibodies into a safe harbor locus such as an albumin locus in an animal in vivo.
    Type: Application
    Filed: December 10, 2025
    Publication date: October 1, 2026
    Applicant: Regeneron Pharmaceuticals, Inc.
    Inventors: Cheng Wang, Suzanne Hartford, Guochun Gong, Christos Kyratsous, Brian Zambrowicz, George D. Yancopoulos
  • Publication number: 20260303600
    Abstract: Embodiments include methods performed by a data collection coordination function (DCCF) of a communication network. Such methods include receiving from a service consumer network function (NFc) a first service request for data and determining a service producer network function (NFp) that produces the data. Such methods include sending to a network repository function (NRF) a request for a second access token granting DCCF permission to access the data on behalf of NFc. The request includes client credentials assertion (CCA) associated with one of DCCF and NFc, and additional credentials assertion (ACA) associated with the other of DCCF and NFc. Such methods include receiving from the NRF the second access token, including subject claim identifying one of DCCF and NFc and additional claim identifying the other of DCCF and NFc. Such methods include sending to the NFp a second service request including the second access token, the CCA, and the ACA.
    Type: Application
    Filed: March 21, 2024
    Publication date: October 1, 2026
    Inventors: Christine Jost, Cheng Wang, Yunjie Lu, Songmao Li, Dan Xu
  • Publication number: 20260291738
    Abstract: Embodiments include methods for a consumer network function (NFc). Such methods include sending, to a network repository function (NRF), a first request for a first access token associated with a machine learning (ML) model that is produced, owned, and/or maintained by a producer NF (NFp). The first request includes an analytics identifier (ID) associated with the ML model, a vendor ID associated with the NFc, and an ID associated with the NFp. Such methods include receiving from the NRF a first response including the first access token and sending to the NFp a second request for the ML model. The second request includes the first access token, the analytics ID, and the vendor ID associated with the NFc. Such methods include receiving from the NFp a second response including a universal resource locator associated with a second NF of the communication network, from which the ML model can be obtained.
    Type: Application
    Filed: November 2, 2023
    Publication date: September 24, 2026
    Inventors: Cheng Wang, Christine Jost, Ferhat Karakoc, Songmao Li, Dan Xu, Ulf Mattsson, Zhang Fu
  • Publication number: 20260283564
    Abstract: A medical device includes a memory, a processor and a display. The memory is used for storing an executable program, which, when executed by the processor, causes the device to acquire a patient's patient data including monitoring data of vital sign parameters of the patient; analyzing the patient data according to preset rules to obtain the patient state of the patient and a comparison result of at least one vital sign parameter associated with the patient state and a preset alarm condition, the patient state comprising the overall state, the state of the physiological system, the state of an organ, the state of a physiological part and the state of tissue; and presenting in the display the patient state in a body map, and presenting, using text or graphics, the comparison result of the at least one vital sign parameter associated with the patient state and the preset alarm condition.
    Type: Application
    Filed: May 22, 2026
    Publication date: September 24, 2026
    Inventors: Cheng WANG, Lin Tan, Xuelei Wu, Sanchao Liu, Weiwei Yuan
  • Publication number: 20260283723
    Abstract: A puncture operation robot and a control method therefor are disclosed. The control method includes: obtaining, by a force sensing module, a first axial force on an ultrasonic probe; calculating a second axial force on the ultrasonic probe along a central axial direction according to the first axial force and a preset force perception model; calibrating, by an optical positioning acquisition module, a normal vector of a contact point between the ultrasonic probe and skin; a normal pressure of the ultrasonic probe on the skin is calculated according to the second axial force and the normal vector; in response to the normal pressure being greater than or equal to a force criterion threshold, controlling a mechanical arm to stop pressing down; and displaying, by a display module in real time, images of an area to be punctured acquired by an ultrasonic image perception module and the optical positioning acquisition module.
    Type: Application
    Filed: August 22, 2023
    Publication date: September 24, 2026
    Inventors: Cheng WANG, Shijia CHEN, Yongcheng ZHANG, Xiaodong CHEN, Hao LUO, Chichi LI, Zexin CHEN
  • Publication number: 20260281116
    Abstract: A method at a protocol translation entity. The method includes receiving, from a Non-3GPP access point, an authentication request message of a first protocol type for a UE that includes an identity of the UE. The method also includes translating the authentication request message of the first protocol type to a corresponding authentication request message of a second protocol type and transmitting to an entity for authentication the corresponding authentication request message of a second protocol type that includes the identity of the UE.
    Type: Application
    Filed: May 5, 2026
    Publication date: September 17, 2026
    Applicant: Telefonaktiebolaget LM Ericsson (publ)
    Inventors: David CASTELLANOS ZAMORA, Daniel NILSSON, Stefan ROMMER, Cheng WANG, Chunbo WANG
  • Patent number: D1150082
    Type: Grant
    Filed: June 13, 2025
    Date of Patent: September 29, 2026
    Assignee: Shenzhen EDUP Electronics Technology Co., Ltd
    Inventors: Chunping Zhou, Cheng Wang
  • Patent number: D1150083
    Type: Grant
    Filed: June 13, 2025
    Date of Patent: September 29, 2026
    Assignee: Shenzhen EDUP Electronics Technology Co., Ltd
    Inventors: Chunping Zhou, Cheng Wang
  • Patent number: D1155330
    Type: Grant
    Filed: September 26, 2025
    Date of Patent: October 27, 2026
    Assignee: NINGBO DELI TOOLS CO., LTD
    Inventor: Cheng Wang